Nebenwirkungen · Aldara
ALDARA 5% cream · Abschnitt 4.8 · PDF-Seite 11
HOS-088053 · Präparat HOS-083607
In clinical trials of imiquimod cream 3 times weekly for 4 or 8 weeks the most frequently occurring application site reactions were itching at the target site (14%) and burning at the target site (5%). Severe erythema (24%) and severe scabbing and crusting (20%) were very common. Local skin reactions, such as erythema, are probably an extension of the pharmacologic effect of imiquimod cream. See 4.2 and 4.4 for information on rest periods.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-18T11:40:00Z · SHA-256 29a2c6949b9e74d0aba2dc8c33290a7bc20b103110a06b748f4e53afb53b0ce7 · Passage 3e9a951192a201e5a65b8e8caf3aacda4f2c68736fbce975037728989cf11306 · Zeichen 11557–12000 im Abschnitt